Trump’s Medicaid changes offer states new powers to lower drug costs — with a catch

Stat News

31 January 2020 - The Trump administration on Thursday unveiled a powerful new tool for states to rein in prescription drug spending. 

But there’s a catch: States can only wield their newfound power if they accept a cap on the federal funding they get for their Medicaid program.

The new tool on offer would effectively help states negotiate lower prices directly with pharmaceutical companies by denying coverage for certain drugs.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing , Medicaid